Patients afflicted with acute psoriasis benefit from topical corticosteroidsAn application of topical corticosteroids and maintenance with a less potent agent in the short run could help patients with intertriginous psoriasis (IP), according to a study conducted by Alexander Kreuter, M.D, from Ruhr University of Bochum, Germany, and colleagues.

The study refuted all myths about side effects related with long-term use of topical corticosteroids.